A brief research report found that Medicare beneficiaries taking several commonly prescribed medications could see ...

Pfizer (PFE) and Bristol-Myers Squibb (BMY) are bought for the same underlying reason: the search for new drugs to replace ...

Wells Fargo analyst Mohit Bansal lowered the firm’s price target on Bristol Myers (BMY) to $60 from $65 and keeps an Equal ...

Medicare beneficiaries using lower-priced negotiated drugs experienced out-of-pocket savings under the Medicare Drug Price ...

Ann Jackson, a Pittsford widow in the last stage of heart failure, wrote a letter to President Donald Trump asking him to ...

Bristol-Myers Squibb is reiterated as a buy, offering attractive valuation and a high 4.23% dividend yield. Click to read ...

Bristol-Myers Squibb is a Hold as replacing lost revenue from Eliquis and Opdivo presents a significant challenge. Click here ...

The number of medicine price concessions hit a new record high in September, the pharmacy negotiator has confirmed.

Track Cohance Lifesciences share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and ...

I recently retired and signed  up for a Medicare Advantage plan in 2026.  I take Xarelto 20 mg and through government ...

On July 31, 2025, President Trump sent letters to 17 of the leading pharmaceutical manufacturers outlining the steps they must take to bring down the prices of prescription drugs in the United States ...